Core Laboratories (CLB) Tops Q3 EPS by 1c, Offers Q4 Guidance
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.50, $0.01 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
